Previous studies evaluating the presence of PD-L1 in primary and metastatic tumor tissue and tumor-infiltrating lymphocytes using IHC or RNA expression have reported expression ranging from 0% to 75.0% (13–17). The gene discussed is CD274; the disease is neoplasm.